Purchase Order HT942525P0045

Award Date 3/25/25
Potential Completion Date 3/30/28
Potential Value $583K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $179,800.00 firm fixed price purchase order contract to Aptagen LLC, a limited liability company, for aptamer development services. The contract, which does not have a set-aside designation, is scheduled for completion on September 19, 2023. Through this contract, Aptagen LLC will provide services related to the development of aptamers, which are synthetic antibodies, including for HIV...
Aptagen LLC was awarded a firm fixed price purchase order valued at two hundred fourteen thousand seven hundred eighty dollars ($214,780) by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. The contract is for the development of aptamers, or synthetic antibodies, for HIV integrase through September 21, 2022. No set-aside designation was used for this procurement. Aptagen will perform the work out of its Jacobus, Pennsylvania facility. As a...
This is a $600,000.00 definitive contract awarded by the National Institute of Allergy and Infectious Diseases, which is part of the Department of Health and Human Services National Institutes of Health, to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products. The contract is for the "Development of Aptamer Affinity Reagents to Immune Targets in Non-Human Disease Models" and has a completion date of September 29, 2021....
This firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Synbio Technologies LLC, a small business located in Monmouth Junction, New Jersey. The $11,994.20 contract is for the delivery of a synthetic plasmid containing the AP50c phage genome, modified to include an eGFP tag. The requirement was originally posted as a special notice by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research Institute of Infectious...
This federal contract award, W81XWH16C0176, was issued by the Defense Health Agency (DHA) to Aptitude Medical Systems Inc., a small business, under the SBIR (Small Business Innovation Research) program. The contract is for a Phase II research and development project focused on developing diagnostic testing products and services for the government. The contract has a ceiling value of $999,990.51 and was awarded on September 23, 2016, with a final completion date of February 27, 2019. Aptitude...
The U.S. Defense Health Agency awarded a $404,505 firm fixed-price purchase order contract to DNA Script Inc., a foreign-owned for-profit company based in Daly City, California. The contract is for the delivery of a benchtop DNA synthesizer and a four-year maintenance plan to support the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). The synthesizer must meet specific technical requirements, including the ability to produce 96 oligonucleotides of 120 nucleotides...
This is a $199,565.00 firm fixed price definitive contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products to the federal government. The contract was awarded on September 13, 2013 with a completion date of June 12, 2014. The contract does not have a set-aside designation. Through this contract, Base Pair...
The U.S. Defense Health Agency (DHA) awarded a $342,690.00 Firm Fixed Price contract to Genedata (USA), Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of Genedata Screener software, maintenance, and support. This sole source contract will enable the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to analyze data generated from its Opera Imaging instruments, supporting critical biomedical and infectious disease research initiatives....
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The award, valued at $14,994, is for the delivery of 5,400 crude peptides by A & A LABS LLC, also doing business as Synthetic Biomolecules. The contract does not have a set-aside designation. A & A LABS LLC is a minority-owned, small disadvantaged business. This contract award may support NIAID's...
This is a $1,303,426.92 firm-fixed-price purchase order awarded by the Defense Health Agency (DHA) to Eitr Biologics, Inc., a small business biotechnology company. The contract is for sorting peripheral blood mononuclear cells from Lassa fever virus survivors to discover and produce monoclonal antibodies for assessment in in vitro and in vivo assays. The original solicitation was issued as a Request for Proposal (RFP) under NAICS code 541380, with a small business size standard of $19.0 million....

This is a sole-source, firm fixed-price contract awarded by the Defense Health Agency to Aptagen LLC, a small, for-profit limited liability company in Jacobus, Pennsylvania. The $582,660 contract is for the generation of DNA aptamer libraries to support the U.S. Army Medical Research Institute of Infectious Diseases' (USAMRIID) project to develop broad-spectrum DNA aptamers to neutralize toxins such as alpha-conotoxins, palytoxins, and viral targets.

Aptagen LLC was selected as the sole source provider due to its proprietary aptamer development processes and ability to generate and characterize the required aptamer libraries within USAMRIID's strict containment protocols. The contract, which has a performance period through March 30, 2028, was awarded on March 25, 2025 under the simplified procedures for commercial item acquisition. No set-aside was used for this procurement.

Generated 9/11/25, 11:05 AM